Skip to McMaster Navigation Skip to Site Navigation Skip to main content

AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US)

Feature image

Posted on March 19, 2024

Read more at Brighter World.

Uncategorized

Brighter World ➚

Whelen Fellowship connects grad students with McMaster startups to drive real-world impact

Uncategorized

June 26, 2025

Daily News ➚

Gailene Tobin Vandenheuvel appointed CEO of McMaster Innovation Park

Uncategorized

May 28, 2025

Daily News ➚

The Forge at McMaster celebrates a decade of innovation

Uncategorized

May 26, 2025